Clinical trial

Efficacy and Safety of CRT, Durvalumab and Surgery for SST

NCT04465968

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention S1 Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention concurrent radiotherapy Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Durvalumab Normalized identity: durvalumabView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Surgery Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Durvalumab Normalized identity: durvalumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy and Safety of CRT, Durvalumab and Surgery for SST

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2020-09-01

PhasePHASE3

Conditions

Superior Sulcus Tumorunresolved

Non-small Cell Lung Cancer Stage IIBunresolved

Non Small Cell Lung Cancer Stage IIIunresolved

Interventions

CisplatinDRUG · verified · RxNorm: cisplatin

S1DRUG

concurrent radiotherapyRADIATION

DurvalumabDRUG · verified · RxNorm: durvalumab

SurgeryPROCEDURE

DurvalumabDRUG · verified · RxNorm: durvalumab

Sponsors & collaborators

National Cancer Center Hospital Eastlead sponsor

AstraZenecacollaborator

Japan Agency for Medical Research and Developmentcollaborator

Japan Clinical Oncology Groupcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04465968 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.